Skip to content

13F-HR filed by BRIDGER MANAGEMENT, LLC

BRIDGER MANAGEMENT, LLC filed this 13F-HR for the quarter ended 2024-03-31, filed 2024-05-15, with 31 holding rows worth $221,834,395.

Accession
0001166309-24-000013
Filed
2024-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2024

A holdings report, 31 entries on the cover page, a total value of $221,834,395 stated on the cover page (in dollars after the unit check, H1), rows summing to $221,834,395 with VALUE read as dollars as filed, 13F file number 028-10079. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Uber Technologies90353T100COM301,457$23,209,174dollars as filed
Eli Lilly and Company532457108COM28,076$21,842,005dollars as filed
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS881624209ADR1,500,000$21,165,000dollars as filed
Morgan Stanley617446448COM187,714$17,675,150dollars as filed
Vertex Pharmaceuticals Incorporated92532F100COM41,050$17,159,311dollars as filed
BATH & BODY WORKS INC COM070830104Stock258,402$12,925,268dollars as filed
ENDEAVOR GROUP HLDGS INC29260Y109CL A COM441,460$11,358,766dollars as filed
Pfizer Inc.717081103COM350,500$9,726,375dollars as filed
TENET HEALTHCARE CORP COM NEW88033G407Stock87,500$9,197,125dollars as filed
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock52,922$7,909,193dollars as filed
SPRINGWORKS THERAPEUTICS INC85205L107COM144,526$7,113,570dollars as filed
TAIWAN SEMICONDUCTOR MFG874039100SPONSORED ADS51,826$7,050,927dollars as filed
CAESARS ENTERTAINMENT INC NE12769G100COM147,625$6,457,118dollars as filed
XENON PHARMACEUTICALS INC COM98420N105Stock146,800$6,319,740dollars as filed
MELCO RESORTS & ENTERTAINMENT585464100ADR865,094$6,237,328dollars as filed
CYTOKINETICS INC23282W605COM NEW69,110$4,845,302dollars as filed
GERON CORP374163103COM1,338,084$4,415,677dollars as filed
DEXCOM INC COM252131107Stock28,900$4,008,430dollars as filed
QUANTERIX CORP74766Q101COMMON STOCK154,900$3,649,444dollars as filed
ATRICURE INC04963C209COM99,795$3,035,764dollars as filed
CATALYST PHARMACEUTICALS INC14888U101COM184,527$2,941,360dollars as filed
Alphabet Inc. Reg. Shares A02079K305COM13,900$2,097,927dollars as filed
UNIQURE NVN90064101SHS362,349$1,884,215dollars as filed
HILLEVAX INC43157M102COM108,200$1,799,366dollars as filed
Microsoft Corp594918104COM4,230$1,779,646dollars as filed
TERNS PHARMACEUTICALS INC COM880881107Stock246,800$1,619,008dollars as filed
SPOTIFYTECHNOLOGYSAFL8681T102STOK5,265$1,389,434dollars as filed
TOASTINCCLASSCLASSA888787108STOK52,692$1,313,085dollars as filed
Amazon.com, Inc023135106COM7,264$1,310,280dollars as filed
NEXTDECADE CORP65342K105COM67,837$385,314dollars as filed
SURROZEN INC86889P117*W EXP 08/01/203466,666$14,093dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001166309-24-000013this filing2024-05-15acceptance time not in the bulk data set